Literature DB >> 26635027

HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors.

Keiko Yasuma1, Toshio Matsuzaki2, Yoshihisa Yamano3, Hiroshi Takashima2, Masao Matsuoka1, Mineki Saito4.   

Abstract

Among human T cell leukemia virus type 1 (HTLV-1)-infected individuals, the risk of developing HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) across lifetime differs between ethnic groups. There is an association between HTLV-1 tax gene subgroups (subgroup-A or subgroup-B) and the risk of HAM/TSP in the Japanese population. In this study, we investigated the full-length proviral genome sequences of various HTLV-1-infected cell lines and patient samples. The functional differences in the viral transcriptional regulators Tax and HTLV-1 bZIP factor (HBZ) between each subgroup and the relationships between subgroups and the clinical and laboratory characteristics of HAM/TSP patients were evaluated. The results of these analyses indicated the following: (1) distinct nucleotide substitutions corresponding to each subgroup were associated with nucleotide substitutions in viral structural, regulatory, and accessory genes; (2) the HBZ messenger RNA (mRNA) expression in HTLV-1-infected cells was significantly higher in HAM/TSP patients with subgroup-B than in those with subgroup-A; (3) a positive correlation was observed between the expression of HBZ mRNA and its target Foxp3 mRNA in HAM/TSP patients with subgroup-B, but not in patients with subgroup-A; (4) no clear differences were noted in clinical and laboratory characteristics between HAM/TSP patients with subgroup-A and subgroup-B; and (5) no functional differences were observed in Tax and HBZ between each subgroup based on reporter gene assays. Our results indicate that although different HTLV-1 subgroups are characterized by different patterns of viral and host gene expression in HAM/TSP patients via independent mechanisms of direct transcriptional regulation, these differences do not significantly affect the clinical and laboratory characteristics of HAM/TSP patients.

Entities:  

Keywords:  Foxp3; HAM/TSP; HBZ; HTLV-1; Tax; Virus subgroup

Mesh:

Substances:

Year:  2015        PMID: 26635027     DOI: 10.1007/s13365-015-0407-2

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  67 in total

1.  Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP.

Authors:  M Nagai; K Usuku; W Matsumoto; D Kodama; N Takenouchi; T Moritoyo; S Hashiguchi; M Ichinose; C R Bangham; S Izumo; M Osame
Journal:  J Neurovirol       Date:  1998-12       Impact factor: 2.643

2.  Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.

Authors:  Mineki Saito; Masanori Nakagawa; Shun Kaseda; Toshio Matsuzaki; Manabu Jonosono; Nobutaka Eiraku; Ryuji Kubota; Norihiro Takenouchi; Masahiro Nagai; Yoshitaka Furukawa; Koichiro Usuku; Shuji Izumo; Mitsuhiro Osame
Journal:  J Infect Dis       Date:  2003-12-31       Impact factor: 5.226

3.  HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein.

Authors:  Jun Matsumoto; Takayuki Ohshima; Osamu Isono; Kunitada Shimotohno
Journal:  Oncogene       Date:  2005-02-03       Impact factor: 9.867

4.  Subtype C Is associated with increased vaginal shedding of HIV-1.

Authors:  Grace C John-Stewart; Ruth W Nduati; Christine M Rousseau; Dorothy A Mbori-Ngacha; Barbra A Richardson; Stephanie Rainwater; Dana D Panteleeff; Julie Overbaugh
Journal:  J Infect Dis       Date:  2005-06-23       Impact factor: 5.226

5.  Transactivation of proenkephalin gene by HTLV-1 tax1 protein in glial cells: involvement of Fos/Jun complex at an AP-1 element in the proenkephalin gene promoter.

Authors:  W Fu; S R Shah; H Jiang; D C Hilt; H P Dave; J B Joshi
Journal:  J Neurovirol       Date:  1997-02       Impact factor: 2.643

Review 6.  Treatment of hepatitis C: a systematic review.

Authors:  Anita Kohli; Ashton Shaffer; Amy Sherman; Shyam Kottilil
Journal:  JAMA       Date:  2014-08-13       Impact factor: 56.272

7.  Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection.

Authors:  Yosuke Maeda; Hiromi Terasawa; Yuetsu Tanaka; Chisho Mitsuura; Kaori Nakashima; Keisuke Yusa; Shinji Harada
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

8.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 9.  An HTLV-I vaccine: why, how, for whom?

Authors:  G de Thé; R Bomford
Journal:  AIDS Res Hum Retroviruses       Date:  1993-05       Impact factor: 2.205

Review 10.  Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?

Authors:  Jochen Huehn; Julia K Polansky; Alf Hamann
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

View more
  6 in total

Review 1.  Genetic Alterations in Adult T-Cell Leukemia/Lymphoma: Novel Discoveries with Clinical and Biological Significance.

Authors:  Shugo Sakihama; Kennosuke Karube
Journal:  Cancers (Basel)       Date:  2022-05-12       Impact factor: 6.575

2.  Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Satoshi Nozuma; Eiji Matsuura; Daisuke Kodama; Yuichi Tashiro; Toshio Matsuzaki; Ryuji Kubota; Shuji Izumo; Hiroshi Takashima
Journal:  Retrovirology       Date:  2017-04-19       Impact factor: 4.602

3.  Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil.

Authors:  João Américo Domingos; Luana Silva Soares; Larissa M Bandeira; Camila Mareti Bonin; Ana C P Vicente; Louise Zanella; Marco Antonio Moreira Puga; Inês Aparecida Tozetti; Ana Rita Coimbra Motta-Castro; Rivaldo Venâncio da Cunha
Journal:  PLoS One       Date:  2017-04-04       Impact factor: 3.240

4.  Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP.

Authors:  Tadasuke Naito; Jun-Ichirou Yasunaga; Yuichi Mitobe; Kazumasa Shirai; Hiroe Sejima; Hiroshi Ushirogawa; Yuetsu Tanaka; Tatsufumi Nakamura; Kousuke Hanada; Masahiro Fujii; Masao Matsuoka; Mineki Saito
Journal:  Retrovirology       Date:  2018-11-06       Impact factor: 4.602

5.  Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status.

Authors:  Yasuo Shiohama; Tadasuke Naito; Toshio Matsuzaki; Reiko Tanaka; Takeaki Tomoyose; Hiroshi Takashima; Takuya Fukushima; Yuetsu Tanaka; Mineki Saito
Journal:  Retrovirology       Date:  2016-04-27       Impact factor: 4.602

6.  Meta-Analysis of HTLV-1-Infected Patients Identifies CD40LG and GBP2 as Markers of ATLL and HAM/TSP Clinical Status: Two Genes Beat as One.

Authors:  Eduardo Rocha Fukutani; Pablo Ivan Pereira Ramos; José Irahe Kasprzykowski; Lucas Gentil Azevedo; Moreno Magalhães de Souza Rodrigues; João Victor de Oliveira Pimenta Lima; Helton Fábio Santos de Araújo Junior; Kiyoshi Ferreira Fukutani; Artur Trancoso Lopo de Queiroz
Journal:  Front Genet       Date:  2019-11-08       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.